BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36463162)

  • 21. A systematic review of barriers and facilitators for hepatitis B and C screening among migrants in the EU/EEA region.
    Moonen CPB; den Heijer CDJ; Dukers-Muijrers NHTM; van Dreumel R; Steins SCJ; Hoebe CJPA
    Front Public Health; 2023; 11():1118227. PubMed ID: 36875381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of hepatitis B vaccination on acute hepatitis B epidemiology in European Union/European Economic Area countries, 2006 to 2014.
    Miglietta A; Quinten C; Lopalco PL; Duffell E
    Euro Surveill; 2018 Feb; 23(6):. PubMed ID: 29439751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimating hepatitis B virus prevalence among key population groups for European Union and European Economic Area countries and the United Kingdom: a modelling study.
    Trickey A; Bivegete S; Duffell E; McNaughton AL; Nerlander L; Walker JG; Fraser H; Hickman M; Vickerman P; Brooks-Pollock E; Christensen H
    BMC Infect Dis; 2023 Jul; 23(1):457. PubMed ID: 37430220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nosocomial transmission in simultaneous outbreaks of hepatitis C and B virus infections in a hemodialysis center.
    Kondili LA; Genovese D; Argentini C; Chionne P; Toscani P; Fabro R; Cocconi R; Rapicetta M
    Eur J Clin Microbiol Infect Dis; 2006 Aug; 25(8):527-31. PubMed ID: 16835740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B and C virus infection among hemodialysis patients in Yogyakarta, Indonesia: Prevalence and molecular evidence for nosocomial transmission.
    Rinonce HT; Yano Y; Utsumi T; Heriyanto DS; Anggorowati N; Widasari DI; Lusida MI; Soetjipto ; Prasanto H; Hotta H; Hayashi Y
    J Med Virol; 2013 Aug; 85(8):1348-61. PubMed ID: 23919229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccinations in prison settings: A systematic review to assess the situation in EU/EEA countries and in other high income countries.
    Madeddu G; Vroling H; Oordt-Speets A; Babudieri S; O'Moore É; Noordegraaf MV; Monarca R; Lopalco PL; Hedrich D; Tavoschi L
    Vaccine; 2019 Aug; 37(35):4906-4919. PubMed ID: 31327651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Securing sustainable funding for viral hepatitis elimination plans.
    Hatzakis A; Lazarus JV; Cholongitas E; Baptista-Leite R; Boucher C; Busoi CS; Deuffic-Burban S; Chhatwal J; Esmat G; Hutchinson S; Malliori MM; Maticic M; Mozalevskis A; Negro F; Papandreou GA; Papatheodoridis GV; Peck-Radosavljevic M; Razavi H; Reic T; Schatz E; Tozun N; Younossi Z; Manns MP
    Liver Int; 2020 Feb; 40(2):260-270. PubMed ID: 31808281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B and C infection in haemodialysis patients in Libya: prevalence, incidence and risk factors.
    Alashek WA; McIntyre CW; Taal MW
    BMC Infect Dis; 2012 Oct; 12():265. PubMed ID: 23082935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring progress towards elimination of hepatitis B and C in the EU/EEA.
    Sharrock KC; Noori T; Axelsson M; Buti M; Diaz A; Fursa O; Hendrickx G; James C; Klavs I; Korenjak M; Maticic M; Mozalevskis A; Peters L; Rigoni R; Rosinska M; Ruutel K; Schatz E; Seyler T; Veldhuijzen I; Duffell E
    PLOS Glob Public Health; 2022; 2(8):e0000841. PubMed ID: 36962761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of parenterally transmitted hepatitis following exposure to invasive procedures in Italy: SEIEVA surveillance 2000-2021.
    Caminada S; Mele A; Ferrigno L; Alfonsi V; Crateri S; Iantosca G; Sabato M; Tosti ME;
    J Hepatol; 2023 Jul; 79(1):61-68. PubMed ID: 36935022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transmission of Hepatitis B and C Virus Infection Through Body Piercing: A Systematic Review and Meta-Analysis.
    Yang S; Wang D; Zhang Y; Yu C; Ren J; Xu K; Deng M; Tian G; Ding C; Cao Q; Li Y; Chen P; Xie T; Wang C; Wang B; Yao J; Threapleton D; Mao C; Ruan B; Li L
    Medicine (Baltimore); 2015 Nov; 94(47):e1893. PubMed ID: 26632685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changing hepatitis A epidemiology in the European Union: new challenges and opportunities.
    Gossner CM; Severi E; Danielsson N; Hutin Y; Coulombier D
    Euro Surveill; 2015 Apr; 20(16):. PubMed ID: 25953274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [HIV, HBV, or HCV transmission from infected health care workers to patients].
    Puro V; Scognamiglio P; Ippolito G
    Med Lav; 2003; 94(6):556-68. PubMed ID: 14768247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Effectiveness and Cost-Effectiveness of Hepatitis C Screening for Migrants in the EU/EEA: A Systematic Review.
    Greenaway C; Makarenko I; Chakra CNA; Alabdulkarim B; Christensen R; Palayew A; Tran A; Staub L; Pareek M; Meerpohl JJ; Noori T; Veldhuijzen I; Pottie K; Castelli F; Morton RL
    Int J Environ Res Public Health; 2018 Sep; 15(9):. PubMed ID: 30223539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and risk factors of hepatitis B and C virus infections among the general population and blood donors in Morocco.
    Baha W; Foullous A; Dersi N; They-they TP; El alaoui K; Nourichafi N; Oukkache B; Lazar F; Benjelloun S; Ennaji MM; Elmalki A; Mifdal H; Bennani A
    BMC Public Health; 2013 Jan; 13():50. PubMed ID: 23331910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seroprevalence of hepatitis B, hepatitis C and HIV infection among patients undergoing haemodialysis in Buenos Aires, Argentina.
    Pereson MJ; Martínez AP; Isaac K; Laham G; Ridruejo E; Garcia GH; Flichman DM; Di Lello FA
    J Med Microbiol; 2021 Jan; 70(1):. PubMed ID: 33180017
    [No Abstract]   [Full Text] [Related]  

  • 37. Three simultaneous, food-borne, multi-country outbreaks of hepatitis A virus infection reported in EPIS-FWD in 2013: what does it mean for the European Union?
    Gossner CM; Severi E
    Euro Surveill; 2014 Oct; 19(43):. PubMed ID: 25375903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Standardising surveillance of hepatitis E virus infection in the EU/EEA: A review of national practices and suggestions for the way forward.
    Adlhoch C; Manďáková Z; Ethelberg S; Epštein J; Rimhanen-Finne R; Figoni J; Baylis SA; Faber M; Mellou K; Murphy N; O'Gorman J; Tosti ME; Ciccaglione AR; Hofhuis A; Zaaijer H; Lange H; de Sousa R; Avellón A; Sundqvist L; Said B; Ijaz S
    J Clin Virol; 2019 Nov; 120():63-67. PubMed ID: 31590112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strengthening hepatitis B and C surveillance in Europe: results from the two global hepatitis policy surveys (2013 and 2014).
    Lazarus JV; Mozalevskis A; Safreed-Harmon K; Eramova I
    Hepatol Med Policy; 2016; 1():3. PubMed ID: 30288307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hepatitis B in Poland in 2010].
    Stepień M; Czarkowski MP
    Przegl Epidemiol; 2012; 66(2):277-85. PubMed ID: 23101217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.